Back to mobile site

UPDATE: B.Riley Downgrades Bicycle Therapeutics (BCYC) to Neutral

April 13, 2022 3:36 AM EDT Send to a Friend
(Updated - April 13, 2022 4:47 AM EDT)

B.Riley analyst Kalpit Patel downgraded Bicycle Therapeutics (NASDAQ: BCYC) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login